期刊文献+

ent-Kaurene全碳骨架中AB环系的不对称合成

Asymmetric Synthesis of AB Rings in ent-Kaurene Carbon Framework
原文传递
导出
摘要 本课题组前期利用多样性导向合成策略完成ent-kaurene天然产物Xerophilusin I、Neolaxiflorin L、Eriocalyxin B、15-epi-Enmelol全合成工作,为完成该类天然产物的不对称合成,对Horner-Wadsworth-Emmons反应进行了优化,改善了反应的区域选择性,在酸性条件下后处理,将Z/E混合物转化为单一Z构型.基于温和的酸性条件实现了单一构型的转化,提出了氢键辅助的Michael加成/retro-Michael消除的机理猜想.发展了Cu(OTf)_(2)催化的不对称Diels-Alder反应:以烯醇硅醚的双烯体3、β-酮酸酯1为亲双烯体,在噁唑啉为手性配体的条件下,以65%的收率和>19∶1dr值完成AB环的构建. The total synthesis of ent-kaurene natural products of Xerophilusin I,Neolaxiflorin L,Eriocalyxin B,15-epi-Enmelol completed by diversity-oriented synthesis strategy.In this paper,the regioselectivity of Horner-Wadsworth-Emmons reaction was optimized,and a single Z configuration was transformed from Z/E mixture under acidic condition.Based on the conversion of a single configuration under mild acidic conditions,a mechanism for hydrogen bond-assisted Michael addition/retro-Michael elimination is proposed.The asymmetric Diels-Alder reaction with silylenol ether dienyl 3 andβ-ketoate 1 as dienophile was developed.Using Cu(OTf)_(2)as Lewis acid and oxazoline as chiral ligand,AB-ring-skeleton was constructed with 65%yield and>19∶1 dr value.
作者 马文静 朱礼志 章梦珣 李志成 Ma Wenjing;Zhu Lizhi;Zhang Mengxun;Lee Chising(School of Material Science and Chemical Engineering,Chuzhou University,Chuzhou,Anhui 239000;Department of Chemistry,Hong Kong Baptist University,Hong Kong 999077;The First Affiliated Hospital of Shenzhen University,Shenzhen Second People’s Hospital,Shenzhen,Guangdong 518035;College of Pharmacy,Shenzhen University,Shenzhen,Guangdong 518060)
出处 《有机化学》 SCIE CAS CSCD 北大核心 2022年第2期580-589,共10页 Chinese Journal of Organic Chemistry
基金 安徽省高校自然科学一般项目(No.KJ2020B19) 滁州学院启动基金(No.2018qd06)资助项目
关键词 ent-kaurene天然产物 Horner-Wadsworth-Emmons反应 区域选择性 不对称DIELS-ALDER反应 ent-kaurane Horner-Wadsworth-Emmons reaction regioselectivity asymmetric Diels-Alder reaction
  • 相关文献

参考文献1

二级参考文献55

  • 1Sun, H.-D.; Huang, S.-X.; H, Q.-B. Nat. Prod. Rep. 2006, 23, 673.
  • 2Kubo, I.; Xu, Y.-L.; Shimizu, K. Phytother. Res. 2004, 18, 180.
  • 3Kadota, S.; Basnet, P.; Ishii, E.; Tamura, T.; Namba, T. Zentralbl. Bakteriol. 1997, 286, 63.
  • 4Arai, T.; Koyama, Y.; Morita. T.; Kaji, H. Chemotherapy (Tokyo) 1961, 9, 403.
  • 5Hayashi, K.; Hayashi, T.; Sun, H.-D.; Takeda, Y. Cancer Gene Ther. 2000, 7, 45.
  • 6Bohlmann, J.; Meyer-Gauen, G.; Croteau, R. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 4126.
  • 7Turner, R. B.; Ganshirt, K. H.; Shaw, P. E.; Tauber, J. D. J. Am. Chem. Soc. 1966, 88, 1776.
  • 8Church, R. F.; Ireland, T. E.; Marshall, J. A. J. Org. Chem. 1966, 31, 2526.
  • 9Duc, D. K. M.; Fetizon, M.; Lazare, S. J. Chem. Soc., Chem. Commun. 1975, 282.
  • 10Duc, D. K. M.; Fetizon, M.; Lazare, S. Tetrahedron 1978, 34, 1207.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部